Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease.

Allen, Emily; Umoru, Godsfavour; Ajewole, Veronica; Bernicker, Eric

Allen, Emily; Umoru, Godsfavour; Ajewole, Veronica; Bernicker, Eric.

Afiliação

Allen E; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States.
Umoru G; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States.
Ajewole V; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States.
Bernicker E; Texas State University College of Pharmacy and Health Sciences, Houston, TX, United States.

Front Oncol ; 13: 1283360, 2023.

Article em En | MEDLINE | ID: mdl-37941544

Palavras-chave

PD-1/PD-L1 inhibitors; immune checkpoint inhibitors; immune checkpoint-induced pneumonitis; immunotherapy; pulmonary disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos